Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-31 @ 10:51 PM
Study NCT ID:
NCT05390294
Status:
COMPLETED
Last Update Posted:
2022-05-25
First Post:
2022-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Survival With Patients Treated With Salivary Gland Cancer
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D012468', 'term': 'Salivary Gland Neoplasms'}], 'ancestors': [{'id': 'D009062', 'term': 'Mouth Neoplasms'}, {'id': 'D006258', 'term': 'Head and Neck Neoplasms'}, {'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D009059', 'term': 'Mouth Diseases'}, {'id': 'D009057', 'term': 'Stomatognathic Diseases'}, {'id': 'D012466', 'term': 'Salivary Gland Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D013514', 'term': 'Surgical Procedures, Operative'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'OTHER', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 250}, 'targetDuration': '5 Years', 'patientRegistry': True}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2022-01-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2022-05', 'completionDateStruct': {'date': '2022-04-30', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2022-05-22', 'studyFirstSubmitDate': '2022-05-18', 'studyFirstSubmitQcDate': '2022-05-22', 'lastUpdatePostDateStruct': {'date': '2022-05-25', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2022-05-25', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2022-03-30', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Patients survival', 'timeFrame': 'Through study completion, an average of 1 year', 'description': 'Survival of patients treated due to SGC during observation period of minimum 2 years'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Salivary gland cancer', 'Survival', 'Prognostic factors'], 'conditions': ['Salivary Gland Cancer', 'Salivary Gland Neoplasms']}, 'descriptionModule': {'briefSummary': 'Salivary gland malignancies is very heterogenous group of tumors regarding tumor histology and localization. The aim of this study is to assess main clinical and pathological parameters related to patients survival', 'detailedDescription': 'The retrospective study enrolled medical charts of the patients treated due to salivaly gland cancers in the Clinic for maxillofacial surgery at Clinical center of Vojvodina in the period of 1. January 1996. to 31. December 2021. Patients demographics, type of the tumor, localization, TNM status and patohystological parameters were evaluated for patients survival and disease free periods'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Patients treated due to SGC in the Clinic for maxillofacial surgery at Clinical center of Vojvodina', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\nPatients with salivary gland malignancies treted in the Clinic for maxillofacial surgery\n\nExclusion Criteria:\n\nIncomplete medical data Patients with metastatic tumord of salivary gland Patients with recurrent malignancies of salivary glands sent from other clinics'}, 'identificationModule': {'nctId': 'NCT05390294', 'briefTitle': 'Survival With Patients Treated With Salivary Gland Cancer', 'organization': {'class': 'OTHER', 'fullName': 'Clinical Center of Vojvodina'}, 'officialTitle': 'Prognostic Factors for Survival of Patients With Salivary Gland Malignancies', 'orgStudyIdInfo': {'id': '1106012'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Patients free of the disease', 'description': 'Patients treated due to SGC without local recurrence or metastases', 'interventionNames': ['Procedure: Surgical intervention with or without postoperative adjuvant therapy']}, {'label': 'Patients with the disease', 'description': 'Patient with relapse of SGC, metastases or died due to SGC', 'interventionNames': ['Procedure: Surgical intervention with or without postoperative adjuvant therapy']}], 'interventions': [{'name': 'Surgical intervention with or without postoperative adjuvant therapy', 'type': 'PROCEDURE', 'description': 'Surgical intervention with or without postoperative adjuvant therapy', 'armGroupLabels': ['Patients free of the disease', 'Patients with the disease']}]}, 'contactsLocationsModule': {'locations': [{'zip': '11000', 'city': 'Novi Sad', 'country': 'Serbia', 'facility': 'Clinic for maxillofacial surgery Clinical center of Vojvodina', 'geoPoint': {'lat': 45.25167, 'lon': 19.83694}}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Clinical Center of Vojvodina', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal Investigator', 'investigatorFullName': 'Denis Brajković', 'investigatorAffiliation': 'Clinical Center of Vojvodina'}}}}